Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.600
-0.050 (-1.08%)
Jan 21, 2025, 4:00 PM EST - Market closed
Cara Therapeutics Market Cap
Cara Therapeutics has a market cap or net worth of $21.03 million as of January 21, 2025. Its market cap has decreased by -43.47% in one year.
Market Cap
21.03M
Enterprise Value
23.22M
1-Year Change
-43.47%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since January 31, 2014, Cara Therapeutics's market cap has decreased from $282.00M to $21.03M, a decrease of -92.54%. That is a compound annual growth rate of -21.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 21.30M | -23.93% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |